Nan Fung Group Holdings’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Nan Fung Group Holdings’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,696,558	Closed	-$4.29M	–	49
2023 Q4	$4.29M	Hold	1,696,558	–	–	2.67%	8
2023 Q3	$4.05M	Hold	1,696,558	–	–	3.28%	6
2023 Q2	$3.92M	Hold	1,696,558	–	–	2.5%	12
2023 Q1	$4.33M	Hold	1,696,558	–	–	2.94%	7
2022 Q4	$4.26M	Hold	1,696,558	–	–	2.93%	8
2022 Q3	$4.92M	Hold	1,696,558	–	–	3.14%	6
2022 Q2	$7.67M	Hold	1,696,558	–	–	5.27%	6
2022 Q1	$13.6M	Hold	1,696,558	–	–	6.45%	5
2021 Q4	$19.7M	Hold	1,696,558	–	–	5.84%	5
2021 Q3	$21M	Buy	+1,696,558	New	+$19.1M	6.73%	5

Nan Fung Group Holdings's SLGC Position: Q1 2024 in Review

Nan Fung Group Holdings sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 1,696,558 shares — an estimated $4.29M sold.

Nan Fung Group Holdings first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $21M in Q3 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Nan Fung Group Holdings reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Nan Fung Group Holdings sold 1,696,558 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $4.29M.
Nan Fung Group Holdings first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
Nan Fung Group Holdings's SomaLogic, Inc. Class A Common Stock position peaked at $21M in Q3 2021.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Nan Fung Group Holdings's 13F filing for Q1 2024, filed 14 May 2024.